<DOC>
<DOCNO>EP-0627919</DOCNO> 
<TEXT>
<INVENTION-TITLE>
APPLICATION OF 2-AMINO 6-TRIFLUOROMETHOXY BENZOTHIAZOLE (RILUZOLE) FOR OBTAINING A DRUG USEFUL IN THE TREATMENT OF MOTOR NEURON DISEASES
</INVENTION-TITLE>
<CLASSIFICATIONS>A61P2500	C07D27700	A61P900	C07D27782	A61K31428	C07D27780	A61P2100	A61P2528	A61K31425	A61P910	A61P2102	A61P2100	A61K31428	A61K31425	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61P	C07D	A61P	C07D	A61K	C07D	A61P	A61P	A61K	A61P	A61P	A61P	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61P25	C07D277	A61P9	C07D277	A61K31	C07D277	A61P21	A61P25	A61K31	A61P9	A61P21	A61P21	A61K31	A61K31	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
RHONE POULENC RORER SA
</APPLICANT-NAME>
<APPLICANT-NAME>
RHONE-POULENC RORER S.A.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
LOUVEL ERIK
</INVENTOR-NAME>
<INVENTOR-NAME>
LOUVEL, ERIK
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Use of 2-amino-6-(trifluoromethoxy)benzothiazole, 
or a salt of this compound with a pharmaceutically 

acceptable acid, in the manufacture of a medicament for 
use in the treatment of motor neuron diseases. 
Use according to Claim 1 of 2-amino-6-(trifluoromethoxy)benzothiazole, 
or a salt of this compound with 

a pharmaceutically acceptable acid, in the manufacture of 
a medicament for use in the treatment of amyotrophic 

lateral sclerosis. 
Use according to Claim 2 in the manufacture of a 
medicament for use in the treatment of amyotrophic 

lateral sclerosis with early bulbar involvement. 
Use according to Claim 2 in the manufacture of a 
medicament for use in the treatment of amyotrophic 

lateral sclerosis, bulbar form. 
Use according to one of Claims 1 to 4 in the 
manufacture of a medicament comprising 25 to 200 mg of 

2-amino-6-(trifluoromethoxy)benzothiazole. 
</CLAIMS>
</TEXT>
</DOC>
